Among these risk genes, SLC1A2 (which encodes for the excitatory amino acid transporter 2, EAAT2, also called GLT-1) variants, i.e., Gly82Arg, Leu85Pro, and Pro289Arg, are clinically associated with epilepsy [17–19]. This evidence concerns the gene SLC1A2 and epilepsy.